These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29179162)

  • 21. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoclasts and Remodeling Based Bone Formation.
    Kylmaoja E; Nakamura M; Tuukkanen J
    Curr Stem Cell Res Ther; 2016; 11(8):626-633. PubMed ID: 26477623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local communication on and within bone controls bone remodeling.
    Henriksen K; Neutzsky-Wulff AV; Bonewald LF; Karsdal MA
    Bone; 2009 Jun; 44(6):1026-33. PubMed ID: 19345750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of osteoclasts in alveolar bone remodeling.
    Omi M; Mishina Y
    Genesis; 2022 Sep; 60(8-9):e23490. PubMed ID: 35757898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells.
    Kameda T; Mano H; Yamada Y; Takai H; Amizuka N; Kobori M; Izumi N; Kawashima H; Ozawa H; Ikeda K; Kameda A; Hakeda Y; Kumegawa M
    Biochem Biophys Res Commun; 1998 Apr; 245(2):419-22. PubMed ID: 9571166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediators of inflammation and bone remodeling in rheumatic disease.
    Shaw AT; Gravallese EM
    Semin Cell Dev Biol; 2016 Jan; 49():2-10. PubMed ID: 26481971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1.
    Riihonen R; Nielsen S; Väänänen HK; Laitala-Leinonen T; Kwon TH
    Matrix Biol; 2010 May; 29(4):287-94. PubMed ID: 20079835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.
    Mulari MT; Qu Q; Härkönen PL; Väänänen HK
    Calcif Tissue Int; 2004 Sep; 75(3):253-61. PubMed ID: 15148559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoclastic bone resorption: normal and pathological.
    Schepetkin I
    Ann N Y Acad Sci; 1997 Dec; 832():170-93. PubMed ID: 9704046
    [No Abstract]   [Full Text] [Related]  

  • 31. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The critical interplay between bone resorbing and bone forming cells.
    Lerner UH; Kindstedt E; Lundberg P
    J Clin Periodontol; 2019 Jun; 46 Suppl 21():33-51. PubMed ID: 30623989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoclasts: Other functions.
    Park-Min KH; Lorenzo J
    Bone; 2022 Dec; 165():116576. PubMed ID: 36195243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPAR gamma: ally and foe in bone metabolism.
    Wahli W
    Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
    Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The regulatory mechanisms of bone metabolism by semaphorin].
    Hayashi M; Nakashima T; Takayanagi H
    Clin Calcium; 2012 Nov; 22(11):1693-9. PubMed ID: 23103813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats.
    Defranco DJ; Lian JB; Glowacki J
    Endocrinology; 1992 Jul; 131(1):114-21. PubMed ID: 1611989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.